A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer: A study of the CESAR Central European Society for Anticancer Drug Research–EWIV.
Saved in:
| Title: | A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer: A study of the CESAR Central European Society for Anticancer Drug Research–EWIV. |
|---|---|
| Authors: | Bergmann, L.1 l.bergmann@em.uni-frankfurt.de, Maute, L.1, Heil, G.2, Rüssel, J.3, Weidmann, E.4, Köberle, D.5, Fuxius, S.6, Weigang-Köhler, K.7, Aulitzky, W.E.8, Wörmann, B.9, Hartung, G.10, Moritz, B.11, Edler, L.12, Burkholder, I.13, Scheulen, M.E.14, Richly, H.14 |
| Source: | European Journal of Cancer. Jan2015, Vol. 51 Issue 1, p27-36. 10p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
